导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 10.47% | 315/1050 |
| 近一周 | -1.12% | 485/1104 |
| 近一月 | -8.37% | 1015/1103 |
| 近一季 | 16.19% | 61/1092 |
| 近半年 | 13.16% | 232/1070 |
| 近一年 | -4.16% | 647/1018 |
| 近两年 | 41.88% | 575/926 |
| 近三年 | 14.07% | 564/834 |
| 成立以来 | 40.95% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.66% 216/1070 |
5.14% 617/1101 |
- - |
- - |
| 2025 | 18.08% 698/1065 |
11.84% 105/1014 |
6.05% 236/1038 |
13.90% 768/1050 |
-12.59% 945/1065 |
| 2024 | -13.28% 826/1011 |
-9.66% 761/960 |
-6.59% 722/983 |
11.33% 519/991 |
-7.69% 807/1011 |
| 2023 | -16.74% 592/952 |
-0.79% 657/880 |
-9.78% 760/895 |
-7.61% 477/915 |
0.67% 103/952 |
| 2022 | -29.58% 620/867 |
-18.22% 443/773 |
2.93% 632/806 |
-16.91% 680/845 |
0.69% 412/867 |
| 2021 | -4.50% 407/740 |
-3.85% 296/580 |
21.69% 136/659 |
-6.43% 397/704 |
-12.77% 673/740 |
| 2020 | 79.24% 94/554 |
14.66% 21/419 |
35.29% 70/466 |
2.89% 389/517 |
12.30% 278/554 |
| 2019 | 70.17% 43/410 |
28.04% 489/1146 |
5.87% 33/1228 |
16.64% 32/390 |
7.62% 255/410 |
| 2018 | -4.34% 4/349 |
- - |
7.01% 12/990 |
-11.02% 808/1000 |
-10.57% 338/1080 |
| 2017 | 6.44% 151/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.76% 111/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 摩根医疗健康股票A VS. 东吴新产业精选股票A(580008) |